Cite
HARVARD Citation
Brandner, S. et al. (2021). MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-oncology. 23 (9), pp. 1457-1469. [Online].